PL1819362T3 - Preparaty do stosowania miejscowego zawierające nepafenak - Google Patents
Preparaty do stosowania miejscowego zawierające nepafenakInfo
- Publication number
- PL1819362T3 PL1819362T3 PL05825662T PL05825662T PL1819362T3 PL 1819362 T3 PL1819362 T3 PL 1819362T3 PL 05825662 T PL05825662 T PL 05825662T PL 05825662 T PL05825662 T PL 05825662T PL 1819362 T3 PL1819362 T3 PL 1819362T3
- Authority
- PL
- Poland
- Prior art keywords
- nepafenac formulations
- topical
- topical nepafenac
- formulations
- nepafenac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63256204P | 2004-12-02 | 2004-12-02 | |
| PCT/US2005/043545 WO2006060618A2 (en) | 2004-12-02 | 2005-12-02 | Topical nepafenac formulations |
| EP05825662A EP1819362B1 (en) | 2004-12-02 | 2005-12-02 | Topical nepafenac formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1819362T3 true PL1819362T3 (pl) | 2010-12-31 |
Family
ID=35848959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05825662T PL1819362T3 (pl) | 2004-12-02 | 2005-12-02 | Preparaty do stosowania miejscowego zawierające nepafenak |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US7834059B2 (pl) |
| EP (1) | EP1819362B1 (pl) |
| JP (2) | JP4968844B2 (pl) |
| KR (1) | KR101289661B1 (pl) |
| CN (1) | CN101068573A (pl) |
| AR (1) | AR052252A1 (pl) |
| AT (1) | ATE476200T1 (pl) |
| AU (1) | AU2005311738B2 (pl) |
| BR (1) | BRPI0518904B1 (pl) |
| CA (1) | CA2586807C (pl) |
| CY (1) | CY1110780T1 (pl) |
| DE (1) | DE602005022756D1 (pl) |
| DK (1) | DK1819362T3 (pl) |
| ES (1) | ES2348249T3 (pl) |
| HK (1) | HK1104225A1 (pl) |
| MX (1) | MX2007006558A (pl) |
| PL (1) | PL1819362T3 (pl) |
| PT (1) | PT1819362E (pl) |
| RU (1) | RU2007124638A (pl) |
| SI (1) | SI1819362T1 (pl) |
| TW (1) | TWI358290B (pl) |
| UY (1) | UY29238A1 (pl) |
| WO (1) | WO2006060618A2 (pl) |
| ZA (1) | ZA200704763B (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI358290B (en) | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
| US20060257487A1 (en) * | 2005-05-10 | 2006-11-16 | Alcon, Inc. | Suspension formulations of nepafenac and other ophthalmic drugs for topical treatment of ophthalmic disorders |
| EP1906916B1 (en) * | 2005-05-10 | 2008-10-29 | Alcon Inc. | Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders |
| TW200812575A (en) * | 2006-04-28 | 2008-03-16 | Alcon Inc | Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye |
| US20080057022A1 (en) * | 2006-08-30 | 2008-03-06 | Erning Xia | Ophthalmic Pharmaceutical Compositions and Uses Thereof |
| CA2687717A1 (en) * | 2007-05-24 | 2008-12-18 | Aciex Therapeutics, Inc. | Formulations and methods for treating dry eye |
| TWI531362B (zh) * | 2008-07-21 | 2016-05-01 | 艾爾康股份有限公司 | 具有治療劑遞送能力之眼科裝置 |
| TW201023912A (en) | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
| WO2010101971A1 (en) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| WO2010101989A1 (en) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| WO2011068872A2 (en) | 2009-12-03 | 2011-06-09 | Alcon Research, Ltd. | Carboxyvinyl polymer-containing nanoparticle suspension |
| US9532222B2 (en) | 2010-03-03 | 2016-12-27 | Duo Security, Inc. | System and method of notifying mobile devices to complete transactions after additional agent verification |
| US9544143B2 (en) | 2010-03-03 | 2017-01-10 | Duo Security, Inc. | System and method of notifying mobile devices to complete transactions |
| US9467463B2 (en) | 2011-09-02 | 2016-10-11 | Duo Security, Inc. | System and method for assessing vulnerability of a mobile device |
| AU2012351948A1 (en) * | 2011-12-16 | 2014-07-10 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer |
| EP3013790A1 (en) | 2013-06-27 | 2016-05-04 | Mylan Laboratories Ltd. | Process for the preparation of nepafenac |
| CN104490861A (zh) * | 2014-11-21 | 2015-04-08 | 三明欣茂药业有限公司 | 一种缓释型奈帕芬胺眼用制剂 |
| EP3470059B1 (en) | 2015-01-26 | 2020-04-01 | Bausch & Lomb Incorporated | Ophthalmic suspension composition |
| US9930060B2 (en) | 2015-06-01 | 2018-03-27 | Duo Security, Inc. | Method for enforcing endpoint health standards |
| CN107024550A (zh) * | 2016-12-21 | 2017-08-08 | 广州仁恒医药科技股份有限公司 | 奈帕芬胺眼用药物组合物的质控方法 |
| CN106963730A (zh) * | 2016-12-22 | 2017-07-21 | 广州仁恒医药科技股份有限公司 | 高度稳定的奈帕芬胺眼用药物组合物 |
| US10412113B2 (en) | 2017-12-08 | 2019-09-10 | Duo Security, Inc. | Systems and methods for intelligently configuring computer security |
| US11658962B2 (en) | 2018-12-07 | 2023-05-23 | Cisco Technology, Inc. | Systems and methods of push-based verification of a transaction |
| JP6994061B2 (ja) * | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤 |
| CN114272207B (zh) * | 2022-01-21 | 2023-04-11 | 山东诺明康药物研究院有限公司 | 一种纳米晶混悬滴眼液及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226344A (pl) | 1967-07-31 | 1971-03-24 | ||
| SE400966B (sv) | 1975-08-13 | 1978-04-17 | Robins Co Inc A H | Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror |
| US4313949A (en) | 1979-09-26 | 1982-02-02 | A. H. Robins Company, Inc. | Method of producing an inhibitory effect on blood platelet aggregation |
| US4254146A (en) | 1979-10-18 | 1981-03-03 | A. H. Robins Company, Inc. | 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters |
| IL61945A (en) | 1980-02-19 | 1984-09-30 | Robins Co Inc A H | 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them |
| US4503073A (en) | 1981-01-07 | 1985-03-05 | A. H. Robins Company, Incorporated | 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids |
| IL64724A0 (en) | 1981-02-17 | 1982-03-31 | Robins Co Inc A H | 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them |
| US4568695A (en) | 1983-12-07 | 1986-02-04 | A. H. Robins Company, Incorporated | 2-Amino-3-benzoyl-phenethylalcohols and intermediates therefor |
| DE3668450D1 (de) | 1985-03-14 | 1990-03-01 | Smithkline Dauelsberg | 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren. |
| US4851443A (en) | 1985-03-14 | 1989-07-25 | Smith Kline Dauelsberg, Gmbh | Carboxylic acid amides, compositions and medical use thereof |
| US4683242A (en) | 1985-10-28 | 1987-07-28 | A. H. Robins Company, Incorporated | Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters |
| DK406686D0 (da) | 1986-08-26 | 1986-08-26 | Hans Bundgaard | Carboxylsyrederivater |
| US4910225A (en) | 1988-01-27 | 1990-03-20 | Senju Pharmaceutical Co., Ltd. | Locally administrable therapeutic composition for inflammatory disease |
| US5461081A (en) | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| US5624893A (en) | 1993-10-14 | 1997-04-29 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
| US5475034A (en) | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US6066671A (en) * | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
| AR030346A1 (es) | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico |
| AR030345A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
| JP2005525408A (ja) | 2002-05-03 | 2005-08-25 | アルコン，インコーポレイテッド | アンフェナクまたはネパフェナクを用いる血管内皮増殖因子媒介性血管障害の処置方法 |
| JP4500261B2 (ja) | 2003-01-21 | 2010-07-14 | 千寿製薬株式会社 | ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤 |
| TWI358290B (en) | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
-
2005
- 2005-11-23 TW TW094141182A patent/TWI358290B/zh active
- 2005-11-28 AR ARP050104964A patent/AR052252A1/es not_active Application Discontinuation
- 2005-11-29 UY UY29238A patent/UY29238A1/es not_active Application Discontinuation
- 2005-12-02 CN CNA200580041442XA patent/CN101068573A/zh active Pending
- 2005-12-02 EP EP05825662A patent/EP1819362B1/en active Active
- 2005-12-02 ZA ZA200704763A patent/ZA200704763B/xx unknown
- 2005-12-02 MX MX2007006558A patent/MX2007006558A/es active IP Right Grant
- 2005-12-02 RU RU2007124638/15A patent/RU2007124638A/ru unknown
- 2005-12-02 DK DK05825662.9T patent/DK1819362T3/da active
- 2005-12-02 BR BRPI0518904-7A patent/BRPI0518904B1/pt active IP Right Grant
- 2005-12-02 PL PL05825662T patent/PL1819362T3/pl unknown
- 2005-12-02 JP JP2007544521A patent/JP4968844B2/ja active Active
- 2005-12-02 SI SI200531107T patent/SI1819362T1/sl unknown
- 2005-12-02 AT AT05825662T patent/ATE476200T1/de active
- 2005-12-02 AU AU2005311738A patent/AU2005311738B2/en active Active
- 2005-12-02 KR KR1020077012413A patent/KR101289661B1/ko active IP Right Review Request
- 2005-12-02 DE DE602005022756T patent/DE602005022756D1/de active Active
- 2005-12-02 WO PCT/US2005/043545 patent/WO2006060618A2/en active Application Filing
- 2005-12-02 CA CA2586807A patent/CA2586807C/en active Active
- 2005-12-02 US US11/292,484 patent/US7834059B2/en active Active
- 2005-12-02 PT PT05825662T patent/PT1819362E/pt unknown
- 2005-12-02 ES ES05825662T patent/ES2348249T3/es active Active
-
2007
- 2007-09-25 HK HK07110438.2A patent/HK1104225A1/xx unknown
-
2010
- 2010-09-14 CY CY20101100830T patent/CY1110780T1/el unknown
- 2010-09-23 US US12/888,631 patent/US8071648B2/en active Active
-
2011
- 2011-10-05 US US13/253,648 patent/US8324281B2/en active Active
- 2011-11-25 JP JP2011257966A patent/JP2012041368A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200704763B (en) | Topical nepafenac formulations | |
| AP2666A (en) | Topical antiviral formulations | |
| GB0511499D0 (en) | Topical ungual formulations | |
| GB0424891D0 (en) | Topical compositions | |
| PL1848403T3 (pl) | Preparaty bioadhezyjne o działaniu miejscowym | |
| GB0518769D0 (en) | Topical formulations | |
| GB0704141D0 (en) | Topical medicament | |
| IL177566A0 (en) | Pharmaceutical formulations | |
| IL178975A0 (en) | Topical preparation containing ambroxol | |
| GB0426301D0 (en) | Pharmaceutical formulations | |
| GB0423565D0 (en) | Formulation | |
| GB0412530D0 (en) | Formulation | |
| GB0423800D0 (en) | New pharmaceutical formulations | |
| GB0416397D0 (en) | Pharmaceutical formulations | |
| EP1895843A4 (en) | MICOGEL TOPICAL FORMULAS | |
| EP1750721A4 (en) | TOPICAL FORMULATIONS BASED ON CROMOGLYCIC ACID | |
| GB0506035D0 (en) | Improved formulation | |
| GB0405197D0 (en) | Topical ungual formulations | |
| GB0417248D0 (en) | Formulations | |
| IL179208A0 (en) | Intereferon formulations | |
| GB0417226D0 (en) | Formulations | |
| GB0412412D0 (en) | New formulation | |
| GB0409129D0 (en) | New formulation | |
| AU2004901689A0 (en) | Therapeutic formulations | |
| GB0401114D0 (en) | Formulation |